New drug trial targets distressing agitation in Alzheimer's patients

NCT ID NCT06803823

Recruiting now Symptom relief Sponsor: Ono Pharmaceutical Co. Ltd Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational medicine called ONO-2020 can safely reduce agitation in people with Alzheimer's disease dementia. It will involve about 90 patients in Japan who will be randomly assigned to receive either the drug or a placebo while hospitalized. The main goal is to see if the drug improves agitation symptoms and is safe for patients.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aburayama Hospital
RECRUITING

Fukuoka, Japan
Airanomori Hospital
NOT_YET_RECRUITING

Kagoshima, Japan
Aiseikai General Incorporated Foundation, Hirosaki Aiseikai Hospital
RECRUITING

Aomori, Japan
Akita Prefectural Center For Rehabilitation and Psychiatric Medicine
RECRUITING

Akita, Japan
Asuka Hospital
RECRUITING

Tokyo, Japan
Fujisawahospital
RECRUITING

Kanagawa, Japan
Fukui Hospital
RECRUITING

Fukui, Japan
Hatano Kousei Hospital
RECRUITING

Kanagawa, Japan
Hayakawa Clinic
RECRUITING

Hiroshima, Japan
Hizen Psychiatric Center
RECRUITING

Saga, Japan
Hosogi Hospital
RECRUITING

Kochi, Japan
Hotei Hospital
RECRUITING

Aichi, Japan
Ichiyo Mental Hospital
RECRUITING

Kochi, Japan
Iryohojin Shadan Shoshinkai Morinohosupitaru・Aoba
RECRUITING

Miyagi, Japan
Ishiki Hospital
RECRUITING

Kagoshima, Japan
JA-Nagano North Alps Medical Center Azumi Hospital
RECRUITING

Nagano, Japan
Jizenkai Ando Hospital
RECRUITING

Nagano, Japan
Keiseikai Hospital
RECRUITING

Hokkaido, Japan
Kishikai Kishi Hospital
RECRUITING

Gunma, Japan
Koseikai Cocoro Hospital Kusatsu
RECRUITING

Hiroshima, Japan
Kuramitsu Hospital
RECRUITING

Fukuoka, Japan
Maizuru Medical Center
RECRUITING

Kyoto, Japan
Matsubara Hospital
RECRUITING

Fukui, Japan
Medical Corporation Keishinkai Kyowa Hospital
RECRUITING

Akita, Japan
NHO Obihiro National Hospital
RECRUITING

Hokkaido, Japan
Nagaokai Neyagawa Sanatorium
RECRUITING

Osaka, Japan
Nakamura Hospital
RECRUITING

Hiroshima, Japan
Nara Medical University Hospital
NOT_YET_RECRUITING

Nara, Japan
Nishigahara Hospital
RECRUITING

Tokyo, Japan
Nishiyama Hospital
NOT_YET_RECRUITING

Kyoto, Japan
Osaka Institute of Clinical Psychiatry Shin-Abuyama Hospital
RECRUITING

Osaka, Japan
Rainbow & Sea Hospital
RECRUITING

Saga, Japan
Saitama Konan Hospital
RECRUITING

Saitama, Japan
Sansyu Hospital
NOT_YET_RECRUITING

Kagoshima, Japan
Sanyokai Sanyo Hospital
RECRUITING

Yamagata, Japan
Seinan Hospital
RECRUITING

Aomori, Japan
Showa Medical University Northern Yokohama Hospital
RECRUITING

Kanagawa, Japan
Taniyama Hospital
NOT_YET_RECRUITING

Kagoshima, Japan

Conditions

Explore the condition pages connected to this study.

AGITATION ASSOCIATED WITH ALZHEIMER'S DISEASE DEMENTIA